Colin Begg (statistician)

Colin B. Begg is a Scottish biostatistician and epidemiologist. He is an attending biostatistician at the Memorial Sloan-Kettering Cancer Center in New York City.[1] He serves as editor-in-chief of the journal Clinical Trials.[2] He has conducted research on the role of BRCA genetic variants in the development of breast cancer,[3][4] as well as racial disparities in cancer survival rates in the United States.[5]

Colin B. Begg
NationalityScottish
Alma materUniversity of Glasgow
Scientific career
FieldsBiostatistics, epidemiology
InstitutionsMemorial Sloan-Kettering Cancer Center
ThesisStatistical diagnosis (1976)
Doctoral advisorJohn Aitchison

Begg was named a Fellow of the American Statistical Association in 1996.[6]

References

  1. "Colin Begg". Memorial Sloan Kettering Cancer Center. Retrieved 2018-12-07.
  2. "Clinical Trials". SAGE Journals. Retrieved 2018-12-07.
  3. "Breast cancer genes don't have to mean cancer". New Scientist. 2008-01-09. Retrieved 2018-12-07.
  4. Alpert, Bill (2002-10-21). "Scary Statistics". Barron's. Retrieved 2018-12-07.
  5. Reuters (2002-04-24). "Racial Gap in Cancer Survival Is Not Biological, Study Finds". The New York Times. ISSN 0362-4331. Retrieved 2018-12-07. {{cite news}}: |last= has generic name (help)
  6. "ASA Fellows list". American Statistical Association. Retrieved 2021-11-03.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.